Trump again pushes unproven drug as COVID-19 treatment | Inquirer News

Trump again pushes unproven drug as COVID-19 treatment

/ 09:19 PM July 28, 2020

President Donald Trump wears a face mask as he participates in a tour of Bioprocess Innovation Center at Fujifilm Diosynth Biotechnologies, Monday, July 27, 2020, in Morrisville, N.C. (AP Photo/Evan Vucci)

WASHINGTON — A week after appearing to project a more serious tone about the coronavirus, President Donald Trump is back to pushing unproven claims that an anti-malaria drug is an effective treatment and challenging the credibility of the nation’s leading infectious disease expert.

Dr. Anthony Fauci pushed back Tuesday, saying he will keep doing his job.

Article continues after this advertisement

Numerous studies, meanwhile, have shown that the drug, hydroxychloroquine, is not an effective treatment for COVID-19, the disease caused by the coronavirus. And the U.S. Food and Drug Administration recently withdrew an order that allowed the drug’s use as an emergency treatment for COVID-19.

FEATURED STORIES

Yet overnight, after returning from a trip to North Carolina where he promoted efforts to develop a COVID-19 vaccine, Trump retweeted a series of tweets advocating for hydroxychloroquine.

The president also shared a post from the Twitter account for a podcast hosted by Steve Bannon, a former top White House adviser to Trump, accusing Fauci of misleading the public over hydroxychloroquine.

Article continues after this advertisement

Fauci, a leading member of the White House coronavirus task force, pushed back Tuesday during an appearance on ABC’s “Good Morning America.”

Article continues after this advertisement

“I go along with the FDA,” said Fauci, the longtime director of the National Institute for Allergy and Infectious Diseases. “The overwhelming prevailing clinical trials that have looked at the efficacy of hydroxychloroquine have indicated that it is not effective in coronavirus disease.”

Article continues after this advertisement

It’s not the first time Fauci has come under attack from Trump and those close to him.

The president’s top trade adviser, Peter Navarro, who has clashed with Fauci over hydroxychloroquine, recently penned a scathing attack on the doctor that was published by USA Today. The newspaper later said the opinion piece did not meet its standards.

Article continues after this advertisement

In recent nationally televised interviews, Trump himself has described Fauci as “a bit of an alarmist” and accused him of making “mistakes” in his coronavirus guidance to the American people.

Asked if he can continue to do his job when Trump continues to publicly question his credibility, Fauci said Tuesday he’ll press ahead “no matter what” because of the stakes involved.

“I don’t tweet. I don’t even read them, so I don’t really want to go there,” Fauci said. “I just will continue to do my job no matter what comes out because I think it’s very important. We’re in the middle of a crisis with regard to an epidemic, a pandemic. This is what I do. This is what I’ve been trained for my entire professional life and I’ll continue to do it.”

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Asked about claims he’s been misleading the public, Fauci said: “I have not been misleading the American public under any circumstances.”

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: 2019-nCoV, China, Coronavirus, COVID-19, Health, NcoV, nCoV update, News, Outbreak, pandemic, Virus, world, world news, Wuhan

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.